• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒2019感染患者的临床特征及输血指征

Clinical characteristics and indications for blood transfusion in patients with SARS-CoV-2 infection.

作者信息

Sanz Cristina, Faúndez Annabel, García Anna, Rodríguez Marta, Coromoto Jaramillo Anny, Pereira Arturo

机构信息

Blood Bank and Transfusion Service, Hospital Clínic, Barcelona, Spain.

Banc de Sang i Teixits, Barcelona, Spain.

出版信息

Med Clin (Engl Ed). 2022 Sep 9;159(5):230-233. doi: 10.1016/j.medcle.2021.07.029. Epub 2022 Sep 1.

DOI:10.1016/j.medcle.2021.07.029
PMID:36065233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9435025/
Abstract

BACKGROUND

There are few data on the clinical characteristics of COVID-19 patients who require blood transfusion. We aimed to investigate the clinical characteristics and indication for transfusion in COVID-19 patients seen during the epidemic's first wave.

MATERIAL AND METHODS

Cross-sectional study that included all consecutive COVID-19 patients admitted to the Hospital Clínic of Barcelona, Spain, from mid-March to mid-May 2020.

RESULTS

A total of 80 patients received 354 RBC units, 116 plasma units, and 48 platelet units. Median age was 71 years (IQR: 62-76), and 59 (74%) were males. In total, 138 of the 261 transfusion episodes that involved RBCs (59%) were related to spontaneous ( = 94) or procedure-related ( = 44) bleeding. Spontaneous bleeding was more frequent in the retroperitoneal space and the gastrointestinal apparatus. Tracheostomy with endotracheal intubation, surgical interventions, and cannulation of femoral vessels were the main procedures behind non-spontaneous bleeding. Most patients (91%) were on anticoagulants, mostly intermediate- or full-dose heparin.

CONCLUSION

Anticoagulation-related bleeding was a leading cause of blood transfusion in COVID-19 patients during the epidemic's first-wave.

摘要

背景

关于需要输血的新冠病毒病(COVID-19)患者的临床特征,相关数据较少。我们旨在调查在疫情第一波期间收治的COVID-19患者的临床特征及输血指征。

材料与方法

本横断面研究纳入了2020年3月中旬至5月中旬期间连续收治于西班牙巴塞罗那临床医院的所有COVID-19患者。

结果

共有80例患者接受了354个红细胞单位、116个血浆单位和48个血小板单位的输血。中位年龄为71岁(四分位间距:62 - 76岁),59例(74%)为男性。在涉及红细胞的261次输血事件中,总计138次(59%)与自发性出血(n = 94)或与操作相关的出血(n = 44)有关。自发性出血在腹膜后间隙和胃肠道更为常见。气管切开并气管插管、外科手术干预以及股血管插管是导致非自发性出血的主要操作。大多数患者(91%)正在接受抗凝治疗,主要使用中等剂量或全剂量肝素。

结论

在疫情第一波期间,抗凝相关出血是COVID-19患者输血的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e9/9435025/ac8fe1b5cc41/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e9/9435025/ac8fe1b5cc41/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e9/9435025/ac8fe1b5cc41/gr1_lrg.jpg

相似文献

1
Clinical characteristics and indications for blood transfusion in patients with SARS-CoV-2 infection.新型冠状病毒2019感染患者的临床特征及输血指征
Med Clin (Engl Ed). 2022 Sep 9;159(5):230-233. doi: 10.1016/j.medcle.2021.07.029. Epub 2022 Sep 1.
2
Clinical characteristics and indications for blood transfusion in patients with SARS-CoV-2 infection.新型冠状病毒感染患者的临床特征和输血适应证。
Med Clin (Barc). 2022 Sep 9;159(5):230-233. doi: 10.1016/j.medcli.2021.07.008. Epub 2021 Jul 29.
3
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病:治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
4
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.依诺肝素用于伴有 2019 冠状病毒病的门诊患者的一级血栓预防(OVID 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 9;21(1):770. doi: 10.1186/s13063-020-04678-4.
5
Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.血液学中的关键问题:危重症患者的贫血、血小板减少症、凝血病及血液制品输注
Clin Chest Med. 2003 Dec;24(4):607-22. doi: 10.1016/s0272-5231(03)00100-x.
6
Novel Coronavirus Infection (COVID-19) Related Thrombotic and Bleeding Complications in Critically Ill Patients: Experience from an Academic Medical Center.危重症患者新型冠状病毒感染(COVID-19)相关的血栓形成和出血并发症:来自一家学术医疗中心的经验
J Clin Med. 2021 Nov 30;10(23):5652. doi: 10.3390/jcm10235652.
7
Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID-19 in Brazil.巴西 3014 例住院 COVID-19 患者的输血情况、临床特征、合并症和结局。
Vox Sang. 2021 Oct;116(9):983-989. doi: 10.1111/vox.13087. Epub 2021 Feb 26.
8
The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.BLood Evaluation (ABLE) 年龄随机对照试验:描述国际试验中英国资助的部分,英国成本效益分析,以及探索与 12 个月随访期间健康相关生活质量和医疗保健成本相关的次要分析。
Health Technol Assess. 2017 Oct;21(62):1-118. doi: 10.3310/hta21620.
9
Number of RBC units and rate of transfusionto anemic HIV-positive patients assigned to receiveWBC-reduced or non-WBC-reduced RBCs: the viral activation transfusion study experience.分配接受去白细胞或未去白细胞红细胞的贫血HIV阳性患者的红细胞单位数量及输血率:病毒激活输血研究经验
Transfusion. 2001 Jun;41(6):794-8. doi: 10.1046/j.1537-2995.2001.41060794.x.
10
Double-edged sword effect of anticoagulant in COVID-19 infection.抗凝治疗在 COVID-19 感染中的双刃剑效应。
BMJ Case Rep. 2021 Mar 22;14(3):e241955. doi: 10.1136/bcr-2021-241955.

本文引用的文献

1
Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.新型冠状病毒肺炎患者静脉血栓栓塞症与出血的风险评估。
Clin Respir J. 2022 Mar;16(3):182-189. doi: 10.1111/crj.13467. Epub 2022 Jan 21.
2
Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals.COVID-19 大流行期间西班牙的献血和输血:按自治区和医院划分的影响。
Int J Environ Res Public Health. 2021 Mar 27;18(7):3480. doi: 10.3390/ijerph18073480.
3
Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
在 SARS-CoV-2 大流行期间,华盛顿州一个大型医疗保健系统的血液使用和输血需求。
Transfusion. 2020 Dec;60(12):2859-2866. doi: 10.1111/trf.16051. Epub 2020 Aug 28.
4
Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea.韩国人群中新冠病毒肺炎患者的输血需求:韩国一项全国性研究
Br J Haematol. 2020 Sep;190(6):e323-e326. doi: 10.1111/bjh.17030. Epub 2020 Sep 9.
5
Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.COVID-19 感染患者重症监护中血液成分的使用:单中心经验。
Br J Haematol. 2020 Nov;191(3):382-385. doi: 10.1111/bjh.17007. Epub 2020 Oct 21.
6
Effects of the COVID-19 pandemic on supply and use of blood for transfusion.新冠疫情对输血用血供应和使用的影响。
Lancet Haematol. 2020 Oct;7(10):e756-e764. doi: 10.1016/S2352-3026(20)30186-1. Epub 2020 Jul 3.
7
Blood transfusion utilization in hospitalized COVID-19 patients.住院 COVID-19 患者的输血利用情况。
Transfusion. 2020 Sep;60(9):1919-1923. doi: 10.1111/trf.15947. Epub 2020 Jul 4.
8
Blood and blood product use during COVID-19 infection.新型冠状病毒肺炎感染期间的血液及血液制品使用情况。
Am J Hematol. 2020 Jul;95(7):E158-E160. doi: 10.1002/ajh.25823. Epub 2020 Apr 22.
9
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
10
Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome.自发性腹膜后血肿:病因、特征、治疗及预后
J Emerg Med. 2012 Aug;43(2):e157-61. doi: 10.1016/j.jemermed.2011.06.006. Epub 2011 Sep 10.